Internet-Based Cognitive Behavioural Therapy (iCBT) for Anxiety and Depression in Singapore

August 2, 2026 updated by: Gerald Koh, National University of Singapore

Assessing the Clinical and Cost Effectiveness of Internet-Based Cognitive Behavioural Therapy (iCBT) for Anxiety and Depression in Singapore

Cognitive-behavioural therapy (CBT) has a robust evidence base for treating anxiety disorders and depression, including transdiagnostic CBT. Internet-based CBT (iCBT) offers a new approach to delivering these therapies. iCBT is a digital adaptation of traditional CBT that leverages digital platforms to deliver similar therapeutic interventions. iCBT encompasses structured programmes that provide users with tools and techniques to manage mental health issues such as depression and anxiety. The digital format ensures timely access to CBT and typically includes interactive modules, videos, self-assessment tools, and virtual therapist support. This study aims to evaluate the effectiveness of iCBT in reducing symptoms of anxiety and depression, as well as its cost-effectiveness and acceptability in local context.

The main questions it aims to answer are:

  1. Do participants receiving iCBT show a reduction in symptoms of anxiety and/or depression, and does the effectiveness of iCBT vary based on individual user characteristics?
  2. What are the factors that influence the acceptance, adoption, and engagement rates of iCBT among Singaporeans?
  3. Is iCBT more cost-effective as compared to usual care?

Researchers will compare guided iCBT to usual care (traditional CBT) to assess iCBT's clinical effectiveness, cost-effectiveness, and acceptability in Singapore's primary and community healthcare settings.

Participants in the intervention group will:

  1. Undergo guided iCBT intervention consisting of 8 weeks of online modules covering core CBT techniques
  2. Counsellors will schedule 3 regular check-ins
  3. Questionnaires will be administered at 5 timepoints
  4. Selected participants will be invited for a semi-structured interview to assess their experiences with iCBT

Participants in the control group will:

  1. Continue usual care
  2. Questionnaires will be administered at 5 timepoints

A parallel qualitative study involving service providers is required to contextualise trial findings, identify implementation barriers and enablers and inform national scale-up and policy decisions. It aims to explore service providers' experiences, perceptions and contextual factors influencing the implementation of iCBT within routine primary-care and community mental-health services participating in this trial.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This multi-agency collaboration study involves partners from MOH Office for Healthcare Transformation (MOHT), Agency of Integrated Care (AIC), and selected Community Intervention Team (COMIT) providers. Participants will be recruited from COMIT providers, which may include patients referred from the primary healthcare sector. Study visits (e.g. iCBT programme, questionnaires, counsellor check-ins) will be conducted online and/or at COMIT sites, where COMIT are the service providers with AIC.

Research procedures were developed with the MOHT co-investigators to design the study protocol, recruitment and operational workflows, and risk management protocols. MOHT leads the development of the iCBT programme, including but not limited to the mobile application interface, intervention materials, interactive exercises, and homework assignments, which would be tested before rolling out to the research participants. Study evaluations (e.g. data analysis, literature reviews, drafting of manuscripts) will be conducted at NUS.

The study comprises of two components: (1) quantitative and (2) qualitative research.

1) Quantitative Study Design: Clinical-Effectiveness The proposed study design will be a two-arm (intervention-control), single-blind (evaluator-blind) randomised controlled trial to evaluate the clinical effectiveness of iCBT for anxiety and depression in Singapore's primary care and community setting. 390 participants will be recruited and randomised 1:1 to intervention (N = 195) or control (N = 195) groups using stratified block randomisation.

Participants in the intervention group will be required to download the iCBT mobile application on their mobile devices. The guided iCBT intervention will consist of 8 weeks of 8 online modules (1 module per week) covering core CBT techniques, including interactive exercises and homework assignments delivered via the iCBT programme on a mobile application. There is no prescribed duration for each module, participants may complete the weekly exercises at their own pace within the eight-week period. COMIT counsellors will schedule regular check-ins with the participants at Week 3, 5, and end of Week 8 via face-to-face or video sessions to introduce the treatment rationale, practise skills, and assess the participants' progress. The control group will continue usual care, including but not limited to care from GP consultations, standard face-to-face CBT, and/or referral to other mental health services.

All participants - both intervention and control groups - are required to complete up to 6 study visits over the course of 8 to 10 months, with each study visit taking approximately 1 to 2 hours for completion of questionnaires pertaining to primary and secondary outcome measures and/or counsellor check-ins, where applicable. The primary outcome measures include PHQ-9 and GAD-7 while secondary outcome measures include WHO Disability Assessment Schedule (WHODAS), patient satisfaction, healthcare utilisation, and cost-effectiveness. Please refer to the visit schedule below:

  1. Pre-treatment/Baseline - Week 1
  2. Mid-treatment - Week 5
  3. Post-treatment - Week 8
  4. 3 months from baseline

  5. 6 months from baseline

    2a) Qualitative Study Design: Patients Qualitative components will also be incorporated into the project to explore patients' experiences, perceptions, and preferences regarding iCBT for depression and anxiety disorders. The qualitative study will provide deeper insights into the factors that influence treatment engagement, adherence, and satisfaction, which are not fully captured by quantitative measures alone.

    Selected participants in the intervention group will be invited for a 1-hour semi-structured interview. Participants will be recruited using purposive sampling to ensure representation of key groups relevant to the implementation of iCBT. Specifically, patients will be selected from among those who have completed the iCBT programme, with a diverse subset based on age, gender, diagnosis (depression or anxiety), symptom severity, and completion status (completers and non-completers). This approach ensures variation in experiences and perspectives.

    An interview guide will be developed to explore participants' experiences with iCBT and will include open-ended questions to allow participants to share their perspectives in their own words. This semi-structured interview will be conducted by qualified personnel assigned by the study team. This is planned as a 1-1 Interview. The interview will be conducted via video-conferencing, and the session will be audio-recorded and transcribed. During the semi-structured interview for the qualitative survey, participant quotes may be included in research publications or presentations, provided consent is obtained. All quotes will be anonymised.

    Key topics to be covered in the interviews include:

    - Treatment Experience: Participants' overall experience with iCBT.

    - Support from Therapists: The value of guidance from therapists (if applicable) in their treatment journey, including the quality and frequency of support received.

    - Adherence and Engagement: Factors that influenced their adherence to the programme, including motivation, barriers, and facilitators.

    - Suggestions for Improvement: Recommendations for improving the iCBT programme based on their experience.

    2b) Qualitative Study Design: Service Providers A parallel qualitative study involving service providers is required to contextualise trial findings, identify implementation barriers and enablers and inform national scale-up and policy decisions. It aims to explore service providers' experiences, perceptions and contextual factors influencing the implementation of iCBT within routine primary-care and community mental-health services participating in this trial.

    This qualitative descriptive study comprises of semi-structured in-depth interviews that adopt an implementation science lens, drawing on constructs from:

    • RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance), and
    • Consolidated Framework for Implementation Research (CFIR) domains (intervention characteristics, inner setting, outer setting, individual characteristics, and implementation process).

    A purposive sampling approach will be used to ensure diversity across professional roles, practice settings and levels of experience with digital mental health interventions. Sampling will continue until thematic saturation is reached (anticipated n = 10-20 participants), consistent with prior qualitative iCBT implementation studies in healthcare services. Service providers will be recruited directly by the research team or through an email blast to ensure participation is entirely voluntary. Each interview will last approximately 45-60 minutes via secure videoconferencing or in person at AIC office, MOHT office or the COMIT site where the service provider is based at, and the session will be audio-recorded and transcribed. Participant quotes may be included in research publications or presentations, where all quotes will be anonymised.

    Key topics to be covered in the interviews include:

    • Initial perceptions and expectations of iCBT
    • Experiences integrating iCBT into routine workflows
    • Perceived clinical value and patient suitability
    • Digital usability and training adequacy
    • Impact on workload, time, and role boundaries
    • Organisational and system-level enablers or constraints
    • Reflections on sustainability and future improvements

Study Type

Interventional

Enrollment (Estimated)

390

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Singapore
      • Singapore, Singapore, 210052
        • Recruiting
        • [Viriya] Mental Wellness Hub
        • Contact:
      • Singapore, Singapore, 540193
      • Singapore, Singapore, 680280
        • Recruiting
        • [Fei Yue] Family Service Centre (Choa Chu Kang)
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

  1. Quantitative Study - Patients

    Inclusion Criteria:

    • Age ≥21 years

    • Tier 2 - 3 depression and/or anxiety based on PHQ-9 and GAD-7 scores

      • PHQ-9 score of 5 to 19
      • GAD-7 score of 5 to 14
    • Able to provide informed consent

    Exclusion Criteria:

    • Unable to read or understand English (Primary 6 level)
    • Unable to use the internet (e.g. due to lack of internet access or insufficient digital literacy)
    • Does not possess a mobile device or is not able to access the iCBT application
    • Actively experiencing psychosis
    • Suspected with personality disorder
    • Primary concern is obsessive compulsive disorder (OCD)

    • Tier 4 patients with severe depression or anxiety

      • PHQ-9 score of 20 and above
      • GAD-7 score of 15 and above

    • Any suicidal risk or ideation

      • PHQ-9 Question 9 score of more than 2
  2. Qualitative Study - Service Providers

Inclusion Criteria:

  • Are currently or previously have been involved in the delivery, supervision, or implementation of the iCBT programme
  • Have had direct experience supporting patients enrolled in the study
  • Able to provide informed consent

Exclusion Criteria:

  • Have no direct involvement in the iCBT programme; or
  • Have had insufficient exposure to the programme, defined as managing fewer than one referred case or less than one month of involvement at the time of recruitment.
  • Conflict of interest or Supervisory Hierarchy Concerns - Individuals whose participation may create perceived coercion or introduce bias
  • Inability to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: iCBT intervention arm
iCBT intervention arm: Participants undergo 8 weeks of 8 online modules (1 module per week) covering core CBT techniques, including interactive exercises and homework assignments delivered via the iCBT programme on a mobile application. COMIT counsellors will schedule regular check-ins with participants at Week 3, 5, and end of Week 8 via video or face-to-face sessions.
Behavioral: Internet-delivered cognitive behavioural therapy (iCBT)
Guided iCBT in Singapore for mild-to-moderate anxiety and/or depression
Other Names:
  • iCBT
  • Guided iCBT
No Intervention: Control arm
The control group will continue usual care, including but not limited to care from GP consultations, standard face-to-face CBT, and/or referral to other mental health services.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the depression scores (PHQ-9) from baseline at: 5 weeks, 8 weeks, 3 months, 6 months
Time Frame: Baseline, 5 weeks, 8 weeks, 3 months, 6 months
Depression severity is assessed using the Patient Health Questionnaire-9 (PHQ-9). Total scores range from 0 to 27, where 0 indicates no depressive symptoms and 27 indicates the most severe depressive symptoms.
Baseline, 5 weeks, 8 weeks, 3 months, 6 months
Change in the anxiety scores (GAD-7) from baseline at: 5 weeks, 8 weeks, 3 months, 6 months
Time Frame: Baseline, 5 weeks, 8 weeks, 3 months, 6 months
Anxiety severity is assessed using the Generalized Anxiety Disorder-7 (GAD-7) scale. Total scores range from 0 to 21, where 0 indicates no anxiety symptoms and 21 indicates the most severe anxiety symptoms.
Baseline, 5 weeks, 8 weeks, 3 months, 6 months
Change in the functional scores (WHODAS 2.0) from baseline at: 5 weeks, 8 weeks, 3 months, 6 months
Time Frame: Baseline, 5 weeks, 8 weeks, 3 months, 6 months
Disability and functional impairment are assessed using the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). Total scores range from 0 to 48, where 0 indicates no disability and 48 indicates full disability.
Baseline, 5 weeks, 8 weeks, 3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Quality-Adjusted Life Years (QALYs) scores from baseline at: 5 weeks, 8 weeks, 3 months, 6 months
Time Frame: Baseline, 5 weeks, 8 weeks, 3 months, 6 months
Health-related quality of life is assessed using the EQ-5D-5L Index Value. Scores typically range from below 0 to 1, where 1 indicates full health, 0 indicates a state equivalent to death, and values below 0 indicate a health state considered worse than death.
Baseline, 5 weeks, 8 weeks, 3 months, 6 months
Change in health and social care service utilization and associated costs via CSRI from baseline at: 8 weeks, 3 months, 6 months
Time Frame: Baseline, 8 weeks, 3 months, 6 months
Health and social care service utilization and associated costs are assessed using an Adapted Client Service Receipt Inventory (CSRI). Outcomes are reported as the total estimated cost of services used in SGD, calculated by multiplying the self-reported frequency of each service by its established unit cost. There is no maximum score; higher total costs indicate greater service utilization and a higher economic burden.
Baseline, 8 weeks, 3 months, 6 months
Change in self-rated health scores from baseline at: 5 weeks, 8 weeks, 3 months, 6 months
Time Frame: Baseline, 5 weeks, 8 weeks, 3 months, 6 months
Self-rated health is assessed using the EQ-5D-5L Visual Analogue Scale (EQ VAS). Scores range from 0 to 100, where 0 indicates the worst health you can imagine and 100 indicates the best health you can imagine.
Baseline, 5 weeks, 8 weeks, 3 months, 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Semi-structured qualitative study on acceptability and user experience regarding iCBT for selected participants in the intervention arm
Time Frame: Post treatment (after Week 8)
Acceptability and user experience are assessed via qualitative semi-structured interviews. Outcomes will be reported as key themes comprising of treatment experience, support from therapists, adherence and engagement, and suggestions for improvement. As this is a qualitative measure, there is no numerical scale or score.
Post treatment (after Week 8)
Semi-structured qualitative study on service providers' acceptability and experience with iCBT
Time Frame: Post treatment (after Week 8)

Acceptability and user experience for service providers who have utilised iCBT are assessed via qualitative semi-structured interviews. Outcomes will be reported as key themes comprising of:

  • Initial perceptions and expectations
  • Experiences integrating iCBT into routine workflows
  • Perceived clinical value and patient suitability
  • Digital usability and training adequacy
  • Impact on workload, time and role boundaries
  • Organisational and system-level enablers or constraints
  • Reflections on sustainability and future improvements As this is a qualitative measure, there is no numerical scale or score.
Post treatment (after Week 8)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National University of Singapore

Collaborators

Agency for Integrated Care, Singapore
Ministry of Health, Singapore

Investigators

  • Principal Investigator: Gerald C.H. Koh, MBBS, FCFP, PhD, Saw Swee Hock School of Public Health, National University of Singapore

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 2, 2026

Primary Completion (Estimated)

March 1, 2028

Study Completion (Estimated)

March 1, 2028

Study Registration Dates

First Submitted

March 23, 2026

First Submitted That Met QC Criteria

April 12, 2026

First Posted (Actual)

April 16, 2026

Study Record Updates

Last Update Posted (Actual)

August 5, 2026

Last Update Submitted That Met QC Criteria

August 2, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NUS-IRB-2025-562

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Demographics, primary outcome measures, secondary outcome measures, and qualitative measures

IPD Sharing Time Frame

Unending from date of publication

IPD Sharing Access Criteria

The investigator(s) and participating institution(s) agree to provide direct access to source data and documents as necessary for the purposes of study-related monitoring, quality assurance audits, Institutional Review Board (IRB)/Ethics Committee review, and inspections by applicable regulatory authorities.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe